Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.
Clinical trial NCT00159471 · TERMINATED
Trial details
- NCT number
- NCT00159471
- Sponsor
- University of Southern California
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2006-06-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.